UPH - UpHealth stock plunges 33% on Q4 revenue miss

UpHealth (UPH -33.1%) posted lower-than-expected Q4 revenue, hurt by a $14.3M contract, that will allow the Company to redeploy primary care digital dispensaries in India.  The company reported quarterly revenue of $33.9M to $41.7M, the higher end of the range missed analysts estimates by $18.8M. The company said it was impacted by $8.3M of Integrated Care Management revenue that the Company will recognize in 2022.  The Company said it was still in the process of finalizing its financial results for the fourth quarter and full year. UPH expects full year 2022 total revenue between $205M and $233M and adjusted EBITDA of $14M to $19M. The company's said Services generated revenue of $17.7M. The Company recorded its largest volume of telehealth use in the U.S. with over 7.4M minutes of consultations during the quarter.  Press release

For further details see:

UpHealth stock plunges 33% on Q4 revenue miss